Global Chorionic Gonadotrophin Market Size, Share, and Trends Analysis Report, By Type (Naturally Extracted and Recombinant) and By Application (Male Hypogonadism, Female Infertility Treatment, Oligospermic Treatment, and Others), Forecast (2022-2028)

The global chorionic gonadotrophin market is anticipated to grow at a significant CAGR of 7.5% during the forecast period (2022-2028).Chorionic gonadotrophin is used in combination with other fertility drugs to increase a woman’s chance of pregnancy. In men or adolescent boys, chorionic gonadotrophin helps the production of testosterone and sperm. It is also used in male children with cryptorchidism, a specific birth problem of the testes. The global chorionic gonadotrophin market is growing due to the rising prevalence of infertility globally. According to World Health Organization in 2020, an estimation of 48 million couples and 186 million individuals are living with infertility globally. Among them, the major causes of infertility among women were disorders of the ovaries, uterus, endocrine systems, or others and among men were majorly associated with the absence or low level of sperm, problems in the ejection of semen, and others. According to Massachusetts Male Aging Study, it is estimated that erectile dysfunction affects every third of men globally. It also states that some form of erectile dysfunction affects around 52% of men. Therefore, the rising prevalence of infertility globally, and the demand for an effective solution for its treatment is primarily driving the growth of the market.

Additionally, the increasing awareness of chorionic gonadotrophin among healthcare professionals and patients, along with new advancements in products and huge investments in research and development activities is boosting the growth of the market. The chorionic gonadotropin is also used as a marker in cancer, including choriocarcinoma, seminoma, and germ cell tumors, which is anticipated to propel the growth of the global chorionic gonadotropin market during the forecast period.

The North American region is anticipated to hold the major share in the global chorionic gonadotrophin market. This is due to the well-established healthcare infrastructure along with the growing burden of infertility in this region. According to the Center for Disease Control and Prevention in December 2019, an estimation of 6.1 million women of age 15-44 years are there in the US, who can get pregnant but are unable to conceive due to various factors like infertility. According to a report by the Government of Canada in May 2019, the causes of infertility have doubled since the 1980s and about 16% of couples in Canada experience infertility. Therefore, the increasing burden of infertility in the North American region is anticipated to hold the major market share in the forecast period.

The market players are also contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and new drug launches, to stay competitive in the market. For instance, as per the article published in January 2020 by David G. Grenache, chorionic gonadotrophin was initially developed as a test for pregnancy but currently, chorionic gonadotrophin is widely used for the assessment of females with suspected ectopic pregnancy.

Market Coverage

• The market number available for – 2022-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- Sun Pharmaceutical Industries Ltd., Sanzyme, Merck & Co., Inc., Ferring B.V., and Fresenius Kabi Canada, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Chorionic Gonadotrophin Market Report by Segment

By Type

• Naturally Extracted
• Recombinant

By Application

• Male Hypogonadism
• Female Infertility Treatment
• Oligospermic Treatment
• Others

Global Chorionic Gonadotrophin Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa